Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 10 citations · 11 references
Social SciencesHealth SciencesOncologyHealth EconomicsHealth InsuranceOccupational HealthCancer Burden AssessmentEconomic EvaluationHealth Care ProductivityHealthcare Cost AnalysisIndirect CostsOccupational EpidemiologyEconomic Burden Of DiseaseEconomic Burden Of IllnessHealth-related Productivity LossProductivityProductivity Loss MeasurementSocietal Perspective AnalysisWork Productivity LossWorkplace Disability Costs
The objective of this study was to examine indirect costs and workplace productivity loss (defined as an aggregate measure of absenteeism, short-term disability, and long-term disability days) associated with non-Hodgkin lymphoma (NHL) from a societal perspective in a commercially insured working-age United States population. The MarketScan(®) Commercial Claims and Encounters and Health and Productivity Management Databases (2007-2013) were used in this study, with controls matched 3:1 to NHL patients. In comparison to controls, NHL patients incurred significantly more workplace productivity loss (31.99 days; 95% CI: 25.24 days, 38.73 days; p < 0.001) and associated indirect costs ($6302.34; 95% CI: $4973.40, $7631.28; p < 0.001) in the 12-month post-diagnosis period when adjusting for covariates. NHL contributes significantly to losses in workplace productivity and higher associated indirect costs.
11